1036 Treg-specific TCR signaling as a target of cancer immunotherapy

Bibliographic Details
Main Authors: Atsushi Tanaka, Shimon Sakaguchi, Yamin Qian
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797630786337243136
author Atsushi Tanaka
Shimon Sakaguchi
Yamin Qian
author_facet Atsushi Tanaka
Shimon Sakaguchi
Yamin Qian
author_sort Atsushi Tanaka
collection DOAJ
first_indexed 2024-03-11T11:13:01Z
format Article
id doaj.art-f25cf6daa29f49029a5537c3380f7395
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T11:13:01Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-f25cf6daa29f49029a5537c3380f73952023-11-11T18:00:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.10361036 Treg-specific TCR signaling as a target of cancer immunotherapyAtsushi Tanaka0Shimon Sakaguchi1Yamin Qian21Osaka University, Suita, Osaka, Japan4Laboratory of Experimental Immunology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan1Osaka University, Suita, Osaka, Japan
spellingShingle Atsushi Tanaka
Shimon Sakaguchi
Yamin Qian
1036 Treg-specific TCR signaling as a target of cancer immunotherapy
Journal for ImmunoTherapy of Cancer
title 1036 Treg-specific TCR signaling as a target of cancer immunotherapy
title_full 1036 Treg-specific TCR signaling as a target of cancer immunotherapy
title_fullStr 1036 Treg-specific TCR signaling as a target of cancer immunotherapy
title_full_unstemmed 1036 Treg-specific TCR signaling as a target of cancer immunotherapy
title_short 1036 Treg-specific TCR signaling as a target of cancer immunotherapy
title_sort 1036 treg specific tcr signaling as a target of cancer immunotherapy
work_keys_str_mv AT atsushitanaka 1036tregspecifictcrsignalingasatargetofcancerimmunotherapy
AT shimonsakaguchi 1036tregspecifictcrsignalingasatargetofcancerimmunotherapy
AT yaminqian 1036tregspecifictcrsignalingasatargetofcancerimmunotherapy